University of Maryland researchers used machine learning models trained on claims data of adults with diabetes to predict ...
Margaret A. Murray, M.P.A., CEO of the Association for Community Affiliated Plans, says outreach and texting will be key to keeping eligible Medicaid enrollees covered under new redetermination and ...
The FDA has approved Lisraya (brepocitinib) to treat adults with dermatomyositis, rare autoimmune disease. Dermatomyositis ...
The FDA has approved ViiV Healthcare’s Tivicay PD (dolutegravir) for pediatric patients weighing at least 2 kg, according to ...
A large multicenter trial testing intravenous arginine as a treatment for acute pain crises in sickle cell patients has ended ...
The FDA has approved Rasonque (daraxonrasib), a first-in-class targeted therapy for metastatic pancreatic cancer, more than ...
A new study from UCLA has found that insurers saw $3,820 lower monthly costs from the use of biosimilars. Cancer patients ...
Tevimbra plus Ziihera with chemo raises survival in first-line HER2-positive gastroesophageal cancer, offering a new FDA-approved option.
Oregon Health & Science University researchers found sensitive caregiving in infancy can offset ADHD risk linked to higher ...
Leqembi IQLIK expands lecanemab delivery beyond infusion centers, enabling at-home administration while preserving IV as an ...
Medicare Advantage enrollees who developed a new complex condition, such as congestive heart failure or Alzheimer’s disease, were more likely to leave their plan for traditional Medicare the next year ...
Antifungal-first paradigms are challenged by the premise that seborrheic dermatitis is an inflammatory dermatosis, not a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results